Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed the repurchase of 120,000 H-shares on 22 May 2026 via on-exchange transactions, paying an aggregate HKD 0.42 million at prices ranging from HKD 3.45 to HKD 3.47 per share. The volume-weighted average repurchase price stood at HKD 3.4617.
Following the transaction, the company’s outstanding share count (excluding treasury shares) declined marginally by 0.0027% to 4.47 billion. Treasury shares rose to 56.40 million, maintaining total issued shares at 4.52 billion.
The repurchase utilises the mandate approved on 27 May 2025, which authorises the company to buy back up to 451.56 million shares. Cumulative on-market repurchases under this mandate now total 49.75 million shares, representing 11.02% of the issued share base on the mandate date. A 30-day moratorium on new share issues or treasury share disposals runs until 22 June 2026.
Comments